explore -WSS

explore

author：explore 2025-10-01 22:50:10 - browse：9139

Home health and hospice chain Amedisys has chosen a new corporate owner.

Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： How one patient went off dialysis — and others can too

hotspot

WSS

The science behind Janet Jackson's pregnancy at 49

Colonoscopy at 40? Study finds a possible benefit

Paxlovid study fails to answer questions over benefit for broader groups

The science behind Janet Jackson's pregnancy at 49

Menendez indictment could see pharma lose a key ally

Gene therapy has helped boys walk. Can scientists keep it that way?

leisure time

explore

knowledge

DIEP, the 'gold standard' of breast reconstruction, is under threat

After a drawn out lobbying fight, ARPA

Hepatitis C has a cure — but many Americans still lack access to it

Cigna to pay $172 million to settle Medicare Advantage fraud probe

Hepatitis C has a cure — but many Americans still lack access to it

How the Dana

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

The science behind Janet Jackson's pregnancy at 49

explore

Obesity experts on risks of Wegovy, Ozempic weight loss drugs

Senator probes 340B programs at Cleveland Clinic, Bon Secours

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

Why do women spend more than men on medical expenses?

Obesity experts on risks of Wegovy, Ozempic weight loss drugs

Medicare drug price negotiation program allowed for now

hotspot

leisure time

entertainment

leisure time